Despite major advances in dermatology, psoriasis continues to pose diagnostic and therapeutic challenges, often requiring ...
A novel oral therapy that inhibits the interleukin-23 inflammatory pathway provided control of moderate-to-severe psoriasis ...
Everyday Health on MSN
7 Psoriasis Myths and the Facts That Debunk Them
Discover key truths about psoriasis, from symptoms and causes to effective management strategies to improve your quality of ...
For adults and adolescents with moderate-to-severe plaque psoriasis, selective blockade of the interleukin-23 receptor with ...
SAN ANTONIO — In the course of caring for individuals with psoriasis, clinicians should have patients complete the validated ...
Significant rates of depression, anxiety, and sleep disturbances in patients with psoriatic arthritis (PsA) and palmoplantar psoriasis (PPP) were identified, underscoring the need for integrated ...
Once-daily, steroid-free topical foam intentionally formulated to help manage psoriasis across difficult-to-treat areas of ...
The novel, oral interleukin-23 inhibitor icotrokinra bested placebo in multiple skin outcomes among adolescent patients with ...
A cognitive behavioral therapy program delivered by smartphone app improved the mental health and quality of life of people ...
Phase 4 results from the UnlIMMited trial show that risankizumab significantly improves psoriasis (PsO) symptoms in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback